Report overview
Crohn?s disease (CD) is a form of inflammatory bowel disease (IBD), which is comprised of two chronic autoimmune diseases that cause intestinal inflammation: Crohn?s disease (CD) and ulcerative colitis (UC). The pathophysiology of CD is complex, as the disease is characterized by recurring flares that evolve along with periods of inactivity and remission.
This report contains market size and forecasts of Crohn?s Disease Drugs in global, including the following market information:
Global Crohn?s Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Crohn?s Disease Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Crohn?s Disease Drugs companies in 2021 (%)
The global Crohn?s Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Inflammatory Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Crohn?s Disease Drugs include Bayer AG, Amgen, Takeda Pharmaceutical, AbbVie, UCB, Ferring, Eli Lilly, Hoffman-La Roche and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Crohn?s Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Crohn?s Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Crohn?s Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Anti-Inflammatory
Immune system suppressors
Antibiotics
Others
Global Crohn?s Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Crohn?s Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Crohn?s Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Crohn?s Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Crohn?s Disease Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Crohn?s Disease Drugs revenues share in global market, 2021 (%)
Key companies Crohn?s Disease Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Crohn?s Disease Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Amgen
Takeda Pharmaceutical
AbbVie
UCB
Ferring
Eli Lilly
Hoffman-La Roche
Bristol-Myers Squibb
Pfizer
